2Peukens J, Risperidone Study Group. Risperidone in the treatment of patients with chronic schizophrenia:a multi-national, multi-centre, double-blind, parallet-group study versus haloperidol [J]. Br J Psychiatry, 1995,166:712. 被引量：1
3Daniel DG, ZimbroffDL, Potkin SG, et al. Ziprasidone 80mg/day and 160mg/day in the acute exacebation of schizophrenia and schizoaffective disorder: a 6-week placebo-controlled trial [J]. Neuropsychopharmacology,1999, 20(5): 491. 被引量：1
4Keck Jr P, Buffenstein A, Ferguson J, et al. Ziprasidone 40 and 120mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 4-week placebo-controlled trial [J]. Psychoparmacology (Berl), 1998,140(2):173. 被引量：1
5Petit M, Raniwalla J, Tweed J, et al. A comparison of atypical and typical antipsychotic, zotepine versus haloperidol in patients with acute exacerbation of schizophrenia: a parallal-group double-blind trial[J]. Psychopharmacol Bull, 1996, 32:81. 被引量：1
6Tollefson GD, Beasley CM, Tran PV, et al. Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of intemational collaborative trial [J]. Am J Psychiatry,1997, 154:457. 被引量：1
7Gupta S, Droney T, Al-Samarrai S, et al. Olanzapine:weight gain and therapeutic efficacy [J]. J Clin Psychopharmacol, 1999, 19(3):273. 被引量：1
8Copolov DL, Link CGG, Kowalcyk B. A comparison of quetiapine and haloperidol in schzophrenia [J]. Psychol Med, 2000, 30:95. 被引量：1
9Small JG, Hirsch SR,Arvantis LA, et al. Quetiapine in patients with schizophrenia [J]. Arch Gent Psychiatry,1997,54(6):549. 被引量：1
10Martin A, Koenig K, Scahill L, et al. Open-label quetiapine in the treatment of children and adolescents with autistic disorder [J]. J Child Adolesc Psychoparmacol,1999,9(2):99. 被引量：1
